Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 218 | 246 | +28 |
| Shares | 30.2M | 31.4M | +1.20M (+4.0%) |
| Value | $1.13B | $1.80B | +$671.1M (+59.2%) |
New holders (50)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (22)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Point72 Asset Management, L.P. | 65,418 | $2.45M |
| Marshall Wace, LLP | 64,209 | $2.41M |
| Aviva PLC | 39,959 | $1.50M |
| Cornercap Investment Counsel Inc | 35,233 | $1.32M |
| Ziegler Capital Management, LLC | 27,637 | $1.04M |
| Walleye Capital LLC | 23,231 | $871.2K |
| Royce & Associates LP | 22,315 | $836.8K |
| Gsa Capital Partners LLP | 21,852 | $819.0K |
| Alberta Investment Management Corp | 20,982 | $786.8K |
| Panagora Asset Management Inc | 19,785 | $741.9K |
| SG Americas Securities, LLC | 16,870 | $633.0K |
| Versor Investments LP | 14,302 | $536.3K |
| Engineers Gate Manager LP | 12,826 | $481.0K |
| Ergoteles LLC | 10,024 | $375.9K |
| Aquatic Capital Management LLC | 5,700 | $214.0K |
| TCI Wealth Advisors, Inc. | 379 | $14.2K |
| Asset Management One Co.,Ltd. | 151 | $5.66K |
| City State Bank | 100 | $4.00K |
| Advisory Services Network, LLC | 100 | $3.75K |
| Belpointe Asset Management LLC | 15 | $563 |
| Schubert & Co | 3 | $113 |
| Steward Financial Group LLC | 6 | $0 |